Evidence mapPaperPMID 37498817Full record

ArticlePloS one2023

Prescription of oral antidiabetics in Mexico. A cross-sectional study.

Inmaculada Fierro, Osiel Gallardo-Mora, Adela Alba-Leonel, Alfonso Carvajal, Juan Arcadio Molina-Guarneros

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Noninsulin antidiabetic prescription patterns in Colombia: a cross-sectional study.Therapeutic advances in endocrinology and metabolism · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Inmaculada FierroDepartamento de Ciencias de la Salud, Universidad Europea Miguel de Cervantes, Valladolid, Spain.ORCID 0000-0003-4423-4493
Osiel Gallardo-MoraPrograma de Maestría y Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México (UNAM), Mexico, Mexico.
Adela Alba-LeonelEscuela Nacional de Enfermería y Obstetricia, Universidad Nacional Autónoma de México (UNAM), Mexico, Mexico.
Alfonso CarvajalUniversidad de Valladolid, Valladolid, Spain.
Juan Arcadio Molina-GuarnerosDepartamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico, Mexico.
Universidad Nacional Autónoma de México · MXUniversidad de Valladolid · ESUniversidad Europea Miguel de Cervantes · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2016 diabetes was declared an epidemic and a health emergency in Mexico. As the rationale of the treatment is to achieve target glycemia levels, the appropriateness of the medications used is important. The aim of this study is to learn the pattern of antidiabetic drug prescription and factors associated with inappropriate prescription in Mexico. A retrospective cross-sectional drug utilization study has been conducted. A randomly selected sample was carefully examined. Out of 3600 clinical records of patients diagnosed with type 2 diabetes mellitus (T2DM), 196 records were revised. As far as control is concerned, 36.7% had their glycemia values in the recommended range. A combination of different antidiabetics was the most common pattern observed (60.7%); the most frequent was that of the association of metformin with whatever oral antidiabetics. Prescriptions were considered as inappropriate in 149 cases (76.0%); younger age and lack of nutritional assessment was significantly related to inappropriate prescription. A trend to use more drugs for treating T2DM has been consistently observed. Despite using so many drugs, most of the patients are not controlled. Avoiding inappropriate prescription by following current guidelines may contribute to a better control and, in turn, decrease morbidity and mortality for this cause.

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsCross-Sectional StudiesDrug PrescriptionsHumansMexicoRetrospective StudiesHypoglycemic Agents

Identifiers

PMID37498817
PMCPMC10373993
OpenAlexW4385300995

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.